These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Emerging Roles of Coronavirus in Autoimmune Diseases. Zhou SY; Zhang C; Shu WJ; Chong LY; He J; Xu Z; Pan HF Arch Med Res; 2021 Oct; 52(7):665-672. PubMed ID: 33875273 [TBL] [Abstract][Full Text] [Related]
27. Nervous system-related tropism of SARS-CoV-2 and autoimmunity in COVID-19 infection. Weissert R Eur J Immunol; 2024 Jan; 54(1):e2250230. PubMed ID: 37733584 [TBL] [Abstract][Full Text] [Related]
28. Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era. Azimi SZ; Firooz A; Murrell DF; Daneshpazhooh M Dermatol Ther; 2020 Nov; 33(6):e13956. PubMed ID: 32621628 [TBL] [Abstract][Full Text] [Related]
29. Ocular Pathology and Occasionally Detectable Intraocular Severe Acute Respiratory Syndrome Coronavirus-2 RNA in Five Fatal Coronavirus Disease-19 Cases. Reinhold A; Tzankov A; Matter MS; Mihic-Probst D; Scholl HPN; Meyer P Ophthalmic Res; 2021; 64(5):785-792. PubMed ID: 33472206 [TBL] [Abstract][Full Text] [Related]
30. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection. Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R Front Immunol; 2021; 12():686462. PubMed ID: 34276672 [TBL] [Abstract][Full Text] [Related]
31. How signalling games explain mimicry at many levels: from viral epidemiology to human sociology. Casey W; Massey SE; Mishra B J R Soc Interface; 2021 Feb; 18(175):20200689. PubMed ID: 33622145 [TBL] [Abstract][Full Text] [Related]
32. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. Gracia-Ramos AE; Martin-Nares E; Hernández-Molina G Cells; 2021 Dec; 10(12):. PubMed ID: 34944099 [TBL] [Abstract][Full Text] [Related]
33. Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications. Dalakas MC; Bitzogli K; Alexopoulos H Front Immunol; 2021; 12():627285. PubMed ID: 33679770 [No Abstract] [Full Text] [Related]
34. Molecular mimicry may explain multi-organ damage in COVID-19. Angileri F; Legare S; Marino Gammazza A; Conway de Macario E; Jl Macario A; Cappello F Autoimmun Rev; 2020 Aug; 19(8):102591. PubMed ID: 32535095 [No Abstract] [Full Text] [Related]
35. Autoantibodies in severe COVID-19-related acute respiratory distress syndrome: Just innocent bystanders? Umbrello M; Nespoli S; Pisano E; Bonino C; Muttini S Int J Rheum Dis; 2021 Mar; 24(3):462-464. PubMed ID: 33539677 [No Abstract] [Full Text] [Related]
36. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8 Ishii H; Nomura T; Yamamoto H; Nishizawa M; Thu Hau TT; Harada S; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Suzuki T; Park ES; Ken M; Onodera T; Takahashi Y; Kusano K; Shimazaki R; Suzaki Y; Ami Y; Matano T Cell Rep Med; 2022 Feb; 3(2):100520. PubMed ID: 35233545 [TBL] [Abstract][Full Text] [Related]
37. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV. Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X MAbs; 2021; 13(1):1953683. PubMed ID: 34313527 [TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 vaccine candidates in rapid development. Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319 [TBL] [Abstract][Full Text] [Related]
40. Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients? Carnevale S; Giovanetti M; Benvenuto D; Ciccozzi M; Broccolo F Semin Thromb Hemost; 2023 Feb; 49(1):103-104. PubMed ID: 35021248 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]